Equities
  • Price (EUR)1.22
  • Today's Change-0.03 / -2.40%
  • Shares traded361.00
  • 1 Year change-16.44%
  • Beta0.5060
Data delayed at least 15 minutes, as of Feb 16 2026 07:10 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Shanghai Pharmaceuticals Holding Co Ltd is a China-based company mainly engaged in pharmaceutical distribution business. The Company mainly operates four business segments. The Industrial segment is mainly engaged in the research and development, production, and sales of drugs and health products. The Distribution segment is mainly engaged in providing distribution, warehousing, and other value-added pharmaceutical supply chain solutions and related services to pharmaceutical manufacturers and distributors. The Retail segment is mainly engaged in operating and franchising the retail pharmacy network. The Others segment mainly engage in other businesses. The Company mainly operates its businesses in the domestic market.

  • Revenue in HKD (TTM)317.91bn
  • Net income in HKD6.39bn
  • Incorporated1994
  • Employees49.40k
  • Location
    Shanghai Pharmaceuticals Holding Co LtdShanghai Pharmaceutical MansionNo.200 Taicang RoadSHANGHAI 200020ChinaCHN
  • Phone+86 2 163730908
  • Fax+86 2 163289333
  • Websitehttps://www.sphchina.com/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.